Label: CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL CLEANSER- salicylic acid gel

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated March 1, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient

    Salicylic acid 2%

  • Purpose

    Acne treatment

  • Uses

    • clears acne blemishes and allows skin to heal
    • helps prevent new acne blemishes from forming
  • Warnings

    For external use only

  • When using this product

    skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. if irritation occurs, only use one topical acne medication at a time.

  • Keep out of reach of children.

    If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • use twice daily
    • shake well, wet face, then work product into a lather
    • massage onto face avoiding the eyes
    • rinse well
  • Inactive ingredients

    water, sodium lauroyl sarcosinate, cocamidopropyl hydroxysultaine, glycerin, niacinamide, gluconolactone, sodium methyl cocoyl taurate, PEG-150 pentaerythrityl tetrastearate, xanthan gum, sodium benzoate, sodium hydroxide, hectorite, trisodium ethylenediamine disuccinate, sodium lauroyl lactylate, tetrasodium EDTA, calcium gluconate, ceramide NP, triethyl citrate, caprylyl glycol, ceramide AP, phytosphingosine, cholesterol, hydrolyzed hyaluronic acid, carbomer, benzoic acid, ceramide EOP

  • PRINCIPAL DISPLAY PANEL

    PDPPDP

  • INGREDIENTS AND APPEARANCE
    CERAVE DEVELOPED WITH DERMATOLOGISTS ACNE CONTROL CLEANSER 
    salicylic acid gel
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:75897-112
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SALICYLIC ACID (UNII: O414PZ4LPZ) (SALICYLIC ACID - UNII:O414PZ4LPZ) SALICYLIC ACID20 mg  in 1 mL
    Inactive Ingredients
    Ingredient NameStrength
    WATER (UNII: 059QF0KO0R)  
    SODIUM LAUROYL SARCOSINATE (UNII: 632GS99618)  
    COCAMIDOPROPYL HYDROXYSULTAINE (UNII: 62V75NI93W)  
    GLYCERIN (UNII: PDC6A3C0OX)  
    NIACINAMIDE (UNII: 25X51I8RD4)  
    GLUCONOLACTONE (UNII: WQ29KQ9POT)  
    SODIUM METHYL COCOYL TAURATE (UNII: JVL98CG53G)  
    PEG-150 PENTAERYTHRITYL TETRASTEARATE (UNII: 8L4OOQ76AM)  
    XANTHAN GUM (UNII: TTV12P4NEE)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    HECTORITE (UNII: 08X4KI73EZ)  
    TRISODIUM ETHYLENEDIAMINE DISUCCINATE (UNII: YA22H34H9Q)  
    SODIUM LAUROYL LACTYLATE (UNII: 7243K85WFO)  
    EDETATE SODIUM (UNII: MP1J8420LU)  
    CALCIUM GLUCONATE (UNII: SQE6VB453K)  
    CERAMIDE NP (UNII: 4370DF050B)  
    TRIETHYL CITRATE (UNII: 8Z96QXD6UM)  
    CAPRYLYL GLYCOL (UNII: 00YIU5438U)  
    CERAMIDE AP (UNII: F1X8L2B00J)  
    PHYTOSPHINGOSINE (UNII: GIN46U9Q2Q)  
    CHOLESTEROL (UNII: 97C5T2UQ7J)  
    HYALURONIC ACID (UNII: S270N0TRQY)  
    CARBOMER HOMOPOLYMER, UNSPECIFIED TYPE (UNII: 0A5MM307FC)  
    BENZOIC ACID (UNII: 8SKN0B0MIM)  
    CERAMIDE 1 (UNII: 5THT33P7X7)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:75897-112-0110 mL in 1 TUBE; Type 0: Not a Combination Product08/11/2021
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC Monograph DrugM00608/11/2021
    Labeler - Unette Corporation (011401882)
    Establishment
    NameAddressID/FEIBusiness Operations
    Unette Corporation011401882manufacture(75897-112) , pack(75897-112) , label(75897-112)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!